Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001496
Filing Date
2025-01-15
Accepted
2025-01-15 16:42:10
Documents
1
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 form4-01152025_090106.html 4  
1 form4-01152025_090106.xml 4 9451
  Complete submission text file 0001415889-25-001496.txt   11098
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Tessari Eben (Reporting) CIK: 0001867899 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 25533404